| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |